Significant progress has been made at Tufts University School of Engineering in the development of a small device, about the size of a vitamin pill, that can be swallowed and passed through the gastrointestinal tract to sample the full inventory of microorganisms in an individual’s gastro-intestinal tract.
Biogen collaborator NeuroSense shares secondary PhIIb data for its ALS treatment
NeuroSense announced secondary endpoint data for its ALS treatment, which is a combination of the antibiotic ciprofloxacin and the NSAID celecoxib. In the Phase IIb
December 6, 2023